Advarra Consent Language

January 19, 2024

The Advarra Participant Payments system launched in December 2023 and since that time, the IRB Office has updated its guidance on including language in the consent form.

IRB Director Hire

December 8, 2023

We are pleased to announce the appointment of Lisa Wilson, JD, CHRP, as the IRB Director, effective December 3, 2023.

Submitting Revised Investigator's Drug Brochures and Package Inserts

December 8, 2023

Studies that use drugs and submit Investigator’s Drug Brochures (IDBs) and/or package inserts at initial review need to submit revised IDBs/package inserts to the IRB for the life of the study.

Documenting Study Eligibility

December 8, 2023

A study's research record must include documentation that each participant has met all the eligibility criteria outlined in the IRB-approved protocol/application.

Advarra Research Participant Payment System

December 8, 2023

The university launched new payment platform that allows for payments to research participants for stipends and travel within a single system that is integrated with OnCore, UW’s clinical trial management system.

UROC Review Process

December 8, 2023

The UW Health/SMPH Research Operations Committee reviews all research that utilizes UW Health services, personnel, facilities, or engages with UW Health patients, in order to assess the operational feasibility of the study.

Upcoming IRB for Beginners Workshop

September 12, 2023

This online workshop scheduled for October 4 offers an overview of the IRB process and review procedures.

Interested in Serving on the IRB?

September 12, 2023

If you or someone you know may be interested in serving as an IRB member, please see our new webpage for additional information.

New HIPAA Guidance in Investigator Manual

September 12, 2023

The Investigator Manual has been updated to now include a comprehensive guide to HIPAA Processes & Documentation.

IRB Efficiency Project Two-Year Follow-up Survey

August 17, 2023

The IRB is conducting an IRB Efficiency Project two-year follow-up survey to hear from you.